DarioHealth
DRIO
9 hedge funds and large institutions have $305K invested in DarioHealth in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
10% less funds holding
Funds holding: 10 → 9 (-1)
24% less capital invested
Capital invested by funds: $401K → $305K (-$96K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$12.4K |
| 2 |
AG
Advisor Group
Phoenix,
Arizona
|
+$7.11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$25K |
DRIO Hedge Fund Activity: Q3 2017 in Review
9 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q3 2017, worth a combined $305K — down 24% from $401K a quarter earlier.
Fund positioning in DRIO was balanced in Q3 2017: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $12.4K. The largest seller was Millennium Management, exiting entirely with an estimated $25K sold.
- 9 institutional investors held DarioHealth (DRIO) as of Q3 2017, down from 10 in Q2 2017.
- Funds reported $305K of DarioHealth stock for Q3 2017, down 24% quarter-over-quarter.
- 1 fund opened new DarioHealth positions in Q3 2017 and 1 closed out, a net change of 0 holders.
- The largest DarioHealth buyer in Q3 2017 was Morgan Stanley, an estimated $12.4K added.
- The largest DarioHealth seller in Q3 2017 was Millennium Management, an estimated $25K sold.
Based on aggregated 13F filings for Q3 2017.